PILL
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Price Chart
Latest Quote
$14.94
+0.84 (+5.96%)
Current Price
| Previous Close | $14.10 |
| Open | $14.57 |
| Day High | $15.10 |
| Day Low | $14.63 |
| Volume | 33,223 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.63% |
| Net Assets | $13.68M |
| Expense Ratio | 0.98% |
| Category | Trading--Leveraged Equity |
| Fund Family | Direxion Funds |
| Net Asset Value | $14.10 |
| Premium/Discount | 5.95% |
| Quarterly Dividend Yield | 0.63% |
| P/E Ratio | 41.67 |
| Exchange | PCX |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $12.61 |
| SMA50 | $12.51 |
| SMA200 | $10.94 |
| RSI | 74.28 |
| ATR | 0.8030 |
| Rel Volume | 0.50 |
Performance History
| Week | +10.42% |
| Month | +26.08% |
| Quarter | +56.44% |
| 6 Months | +26.64% |
| YTD | +27.17% |
| Year | +184.02% |
| 3 Years | +85.23% |
| 5 Years | -38.07% |
| 10 Years | -32.15% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $14.94 | 33,223 |
| 2026-06-18 | $14.10 | 48,100 |
| 2026-06-17 | $13.83 | 62,900 |
| 2026-06-16 | $13.48 | 76,200 |
| 2026-06-15 | $13.53 | 64,400 |
| 2026-06-12 | $13.53 | 59,600 |
| 2026-06-11 | $13.21 | 47,500 |
| 2026-06-10 | $12.32 | 98,200 |
| 2026-06-09 | $12.18 | 74,100 |
| 2026-06-08 | $11.57 | 16,300 |
| 2026-06-05 | $11.60 | 69,400 |
| 2026-06-04 | $12.08 | 162,500 |
| 2026-06-03 | $11.16 | 68,600 |
| 2026-06-02 | $10.85 | 143,400 |
| 2026-06-01 | $11.90 | 146,800 |
| 2026-05-29 | $12.46 | 23,200 |
| 2026-05-28 | $12.56 | 34,300 |
| 2026-05-27 | $12.46 | 27,400 |
| 2026-05-26 | $12.30 | 35,000 |
| 2026-05-22 | $12.19 | 31,100 |
About Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on PILL.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.